AAB - Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis
Product Lines:
Advantage MD, EHP, Priority Partners and USFHP.
Eligible Population:
Members 3 months and older by December 31 of the measurement year.
Definition:
Percentage of episodes for members ages 3 months and older with a diagnosis of acute bronchitis/bronchiolitis, who were not dispensed an antibiotic medication on or 3 days after the episode. Looks at episodes for any outpatient, telephone, observation or ED visit, e-visit or virtual check-in during the intake period with a diagnosis of acute bronchitis/bronchiolitis, between July 1 of the year prior to the measurement year through June 30 of the measurement year. The measure is reported as an inverted rate: A higher rate indicates appropriate treatment (not prescribed an antibiotic).
Report three age stratifications and a total rate:
- 3 months–17 years.
- 18–64 years.
- 65 years and older.
- Total. The total is the sum of the age stratifications.
Continuous Enrollment:
- 30 days prior to the episode date through 3 days after the episode date (34 total days).
Best Practice and Measure Tips
- Avoid prescribing an antibiotic unless there is a bacterial etiology.
- When antibiotics are needed for a patient with acute bronchitis / bronchiolitis with comorbid conditions: submit codes on the same claim to remove member from measure.
- Examples: HIV, Malignant Neoplasm, Emphysema, COPD
- An episode will not count toward the measure denominator if the member was diagnosed with pharyngitis or a competing diagnosis, if the visit resulted in an inpatient stay on or 3 days after the episode date.
- Not exclusions for this HEDIS measure: asthma and diabetes diagnosis; Symptoms such as fever, cough and wheezing; tobacco use.
- This measure is based on episodes; members may have multiple episodes.
- CDC offers a number of materials and tools about antibiotic resistance, appropriate prescribing and use for common infections.
- Permission is not needed to print, copy, or distribute any materials. Visit the CDC website.
- Telehealth visits are allowed for this measure.
Measure Exclusions
- Members in hospice or using hospice services anytime during the measurement year.
- Members who died any time during the measurement year.
Measure Codes
Diagnosis of acute bronchitis/bronchiolitis (Acute Bronchitis Value Set): J20.3-J20.9, J21.0, J21.1, J21.8, J21.9
Measure Medications
To comply with this measure, episode dates will not count where a new or refill prescription for an antibiotic medication (AAB Antibiotic Medications List) was dispensed 30 days prior to the episode date or was active on the episode date. Otherwise, a dispensed prescription for any of below medication on or 3 days after the episode date, will count.
Description | Prescription |
---|---|
Aminoglycosides |
|
Aminopenicillins |
|
Beta-lactamase inhibitors |
|
First-generation cephalosporins |
|
Fourth-generation cephalosporins |
|
Lincomycin derivatives |
|
Macrolides |
|
Miscellaneous antibiotics |
|
Penicillinase resistant penicillins |
|
Quinolones |
|
Rifamycin derivatives |
|
Second-generation cephalosporin |
|
Sulfonamides |
|
Tetracyclines |
|
Third-generation cephalosporins |
|
Urinary anti-infectives |
|